ATE89735T1 - Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt. - Google Patents

Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.

Info

Publication number
ATE89735T1
ATE89735T1 AT89114307T AT89114307T ATE89735T1 AT E89735 T1 ATE89735 T1 AT E89735T1 AT 89114307 T AT89114307 T AT 89114307T AT 89114307 T AT89114307 T AT 89114307T AT E89735 T1 ATE89735 T1 AT E89735T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparation
treatment
liver extract
virus diseases
virus
Prior art date
Application number
AT89114307T
Other languages
English (en)
Inventor
Thomas Dr Steinbach
S Ken Dr Tanaka
William J Dr Hermann
Carl H Dr Lawyer
Sudhakar S Dr Wagle
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Application granted granted Critical
Publication of ATE89735T1 publication Critical patent/ATE89735T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/02—Burettes; Pipettes
    • B01L3/0289—Apparatus for withdrawing or distributing predetermined quantities of fluid
    • B01L3/0293—Apparatus for withdrawing or distributing predetermined quantities of fluid for liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/10—Devices for withdrawing samples in the liquid or fluent state
    • G01N1/18—Devices for withdrawing samples in the liquid or fluent state with provision for splitting samples into portions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/846—Liver

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Hydrology & Water Resources (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Nutrition Science (AREA)
  • Clinical Laboratory Science (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT89114307T 1988-08-04 1989-08-03 Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt. ATE89735T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/228,364 US5055296A (en) 1988-08-04 1988-08-04 Method of treating chronic fatigue syndrome

Publications (1)

Publication Number Publication Date
ATE89735T1 true ATE89735T1 (de) 1993-06-15

Family

ID=22856877

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89114307T ATE89735T1 (de) 1988-08-04 1989-08-03 Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.

Country Status (6)

Country Link
US (1) US5055296A (de)
EP (1) EP0357958B1 (de)
AT (1) ATE89735T1 (de)
DE (1) DE68906735T2 (de)
ES (1) ES2058418T3 (de)
IE (1) IE61892B1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316775A (en) * 1988-08-04 1994-05-31 Kremers-Urban Company Method of treating hepatitis B infection
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
FR2662353A1 (fr) * 1990-05-22 1991-11-29 Neyroud Andre Savon en pain ou liquide antiseptique puissant, qui detruit les virus du sida, assure l'hygiene corporelle et protege la peau.
CA2078019C (en) * 1991-09-13 2002-08-27 Siegbert Heinrich Bissbort Substance or composition and uses thereof
EP0537722A3 (en) * 1991-10-15 1994-07-13 Kremers Urban Co Porcane liver polypeptides for treating viral infections
JPH05262654A (ja) * 1992-03-18 1993-10-12 Kaken Pharmaceut Co Ltd 慢性疲労症候群治療剤
US5267570A (en) * 1992-12-30 1993-12-07 Preston Myra S Method of diagnosing and treating chronic fatigue syndrome
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5872123A (en) 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US7687057B2 (en) 1998-01-09 2010-03-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs, and uses related thereto
US6350472B1 (en) * 1998-12-14 2002-02-26 Steinbach, Pylant, And Hermann, L.L.C. Method of treating HIV infection with transdermal gel containing mammalian liver extract
US6156349A (en) * 1998-12-14 2000-12-05 Steinbach, Pylant And Herman, L.L.C. Method of treating HIV infection with suppository containing mammalian liver extract
CA2435411A1 (en) * 1999-06-25 2001-01-04 Yissum Research Development Company Of The Hebrew University Of Jerusale M Method of inducing angiogenesis by micro-organs
EP1123707A3 (de) * 1999-12-15 2001-10-17 Gruner, Helmut, Dr.med.vet Verwendung eines Leberextraktes und Leberextrakt dazu
WO2010109009A1 (en) 2009-03-27 2010-09-30 Protea Biopharma N.V. Methods for the detection and treatment of aberrant prion disease
EP2561879A1 (de) 2011-08-23 2013-02-27 Protea Biopharma N.V. Makrophagenaktivierungsfaktor zur Verwendung bei der Behandlung des chronischen Ermüdungssyndroms sowie Erkrankungen und Störungen im Zusammenhang mit dem chronischen Ermüdungssyndrom
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2017373A1 (de) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
US3788510A (en) 1972-12-15 1974-01-29 A Collins Container closure
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
US4254103A (en) * 1979-06-08 1981-03-03 Institul de Cercetari Chimicofarmaceutice Hepatoprotector Factor (HF) and method of treatment
US4603122A (en) * 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
US4426324A (en) * 1979-09-28 1984-01-17 Hoffmann-La Roche Inc. Immunopotentiating peptides
DK170068B1 (da) * 1980-11-26 1995-05-15 Ct Holding Sa Analogifremgangsmåde til fremstilling af xanthater
ZA822158B (de) * 1980-12-30 1984-10-01
US4464355A (en) * 1981-03-26 1984-08-07 Hooper Trading Co. Serum-free and mitogen-free T-cell growth factor and process for making same
US4603219A (en) * 1981-05-21 1986-07-29 Syntex (U.S.A.) Inc. 1,3-dibenzyloxy-2-acetoxymethoxypropane, intermediate for 9-(1,3-dihydroxy-2-propoxymethyl)guanine
HU185263B (en) * 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
US4614651A (en) * 1981-07-12 1986-09-30 Damon Biotech, Inc. Interferon epsilon
US4420398A (en) * 1981-08-13 1983-12-13 American National Red Cross Filteration method for cell produced antiviral substances
US4537878A (en) * 1981-10-05 1985-08-27 Tni Pharmaceuticals, Inc. Process for using endogenous enkephalins and endorphins to stimulate the immune system
FR2514646A1 (fr) * 1981-10-16 1983-04-22 Grenet Edouard A titre de medicament protegeant ou restaurant la formule sanguine blanche, notamment la lignee lymphocytaire, le desoxyribonucleinate de magnesium et son association avec la fraction antitoxique du foie
JPS58152815A (ja) * 1982-03-05 1983-09-10 Tamio Nishimura 医療用抗ウイルス剤
US4596798A (en) * 1982-03-30 1986-06-24 The United States Of America As Represented By The Secretary Of The Army 2-acetylpyridine thiosemicarbazones as antiviral agents
US4629811A (en) * 1982-05-03 1986-12-16 Eli Lilly And Company 3-sulfonylamino-4-aminobenzophenone derivatives
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
US4609661A (en) * 1982-08-09 1986-09-02 Syntex (U.S.A.) Inc. Substituted 9-(1-O- or 3-O-monosubstituted or 1,3-di-O-substituted propoxymethyl)purines as antiviral agents
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4612314A (en) * 1982-12-22 1986-09-16 Syntex (U.S.A.) Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4625026A (en) * 1982-12-30 1986-11-25 Biomeasure, Inc. 2-amino-4-oxo-tricyclicpyrimidines having antiviral activities against herpes simplex virus type II infections
DE3315808A1 (de) * 1983-04-30 1984-10-31 Bayer Ag, 5090 Leverkusen Antivirale mittel
US4631149A (en) * 1983-07-25 1986-12-23 University Of Illinois Antiviral eudistomins from a marine tunicate
US4614731A (en) * 1983-09-15 1986-09-30 Hoffmann-La Roche Inc. Peptide having immunopotentiating activity similar to thymosin alpha1
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
IN161706B (de) * 1983-10-05 1988-01-16 Solco Basel Ag
CS238038B1 (en) * 1983-10-07 1985-11-13 Antonin Holy Medical drug with antivirus effect
AU567140B2 (en) * 1984-01-06 1987-11-12 Shionogi & Co., Ltd. Sulphonamido-benzamide derivatives
US4621140A (en) * 1984-02-23 1986-11-04 Syntex (U.S.A.) Inc. Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxymethyl)-purines and certain derivatives
US4628063A (en) * 1984-03-08 1986-12-09 Dana P. Brigham Antiviral pharmaceutical preparations and methods for their use
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
US4595588A (en) * 1984-05-24 1986-06-17 Board Of Regents, The University Of Texas System Natural inhibitor that protects against viral infections
US4626524A (en) * 1984-08-30 1986-12-02 The General Hospital Corporation Antiviral peptides
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
US4644055A (en) * 1984-12-17 1987-02-17 E. I. Du Pont De Nemours And Company Method for preparing specific inhibitors of virus-specified proteases
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
US4605659A (en) * 1985-04-30 1986-08-12 Syntex (U.S.A.) Inc. Purinyl or pyrimidinyl substituted hydroxycyclopentane compounds useful as antivirals
US4670437A (en) * 1985-09-11 1987-06-02 Eli Lilly And Company Antiviral pyridazine hydrazones
US4699898A (en) * 1985-12-26 1987-10-13 Imreg, Inc. Tripeptides affecting immune response
US4710380A (en) * 1986-04-04 1987-12-01 Imreg, Inc. Treatment of autoimmune disorders with immunoamplifiers
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment

Also Published As

Publication number Publication date
EP0357958A2 (de) 1990-03-14
DE68906735T2 (de) 1993-09-09
EP0357958A3 (en) 1990-12-12
IE61892B1 (en) 1994-11-30
EP0357958B1 (de) 1993-05-26
ES2058418T3 (es) 1994-11-01
IE892548A1 (en) 1991-02-13
DE68906735D1 (de) 1993-07-01
US5055296A (en) 1991-10-08

Similar Documents

Publication Publication Date Title
ATE89735T1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
DK184186D0 (da) Terapeutisk praeparat til behandling af virussygdomme
DK162983D0 (da) Fremgangsmade til fremstilling af steriliseret plasma og plasmaderivater
EP0270317A3 (de) Pharmaceutische Zuberatung zur Behandlung von Virus-Krankheiten
NO922953L (no) Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter
ATE20309T1 (de) Pharmazeutische zubereitung.
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
DE3751772T2 (de) Impfstoff zur behandlung von hsv
ES2113910T3 (es) Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus.
DK462688D0 (da) Anvendelse af nukleosider til fremstilling af laegemiddel til behandling af sygdomme foraarsaget af retrovirus eller hepatitis b virus
NO880935D0 (no) Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning.
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
ATE88752T1 (de) Inaktivierung von human immunodeficiency virus (hiv) in proteinhaltigen loesungen durch phenole.
DK0480391T3 (da) Emulgatorfrie emulsionspolymerer, deres fremstilling og deres anvendelse i farmaceutiske præparater med forlænget frigivelse af virksomt stof
DK0504191T3 (da) Præparat til behandling af HIV-infektioner
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
JPS5545618A (en) Thermal treatment of fraction containing glycoprotein which accelerates differentiation and proliferation of human granulocyte
ES507444A0 (es) Procedimiento para inactivar virus de la fiebre aftosa.
DE69210737D1 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
DE69422980D1 (de) Extrakte von Piliostigma thonningii, deren Verwendung und diese enthaltende Zubereitungen
IL90783A0 (en) Antiviral method for human immuno deficiency virus
Dong Genetic Engineering Interferon-? D as an Inhibitor of Poliovirus 1 Replication in FL Cell Cultures
Ekram Markers of HBV, HCV and HDV among multitransfused children

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee